The Food and Drug Administration on July 6 granted full approval to the first therapy for Alzheimer’s that slows the cognitive decline associated with the disease.
amyloid
Here are the eleven from Nature, plus two bonus picks from me.
By age 50 years, 10% of individuals with normal cognitive function are storing amyloid in their brain, and by age 90
Recently, the FDA has approve
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
